Explore prostate cancer treatment options like surgery, radiation, and hormone therapy. Learn how to choose the best approach with your healthcare provider’s guidance and support.
The chance of getting prostate cancer increases with age but genetics can also be a risk factor. Huntsman Cancer Institute genetic counselor Sam Beck answers questions about prostate cancer.
A virtual support group provides a way for members to openly share struggles, 寻找情感支持, and learn coping techniques from experts, creating a unique brotherhood.
From shrinking brain tumors to personalized therapies, our investigators are leading pioneering research, discovering breakthroughs in treatment, and promoting equity-driven care.
The Society of Huntsman Translational Scholars adds Umang Swami, MD, MS, 还有马修·卡温顿, MD, to its cohort that advances cancer testing and treatments through financial support and collaboration.
Two visionary physician leaders take pivotal new roles to amplify innovation and patient-centric advancements in Huntsman Cancer Institute’s quest for a future free from cancer.
Neeraj Agarwal说医学博士, 外航服务公司, observed remarkable outcomes in a larger group of Talapro-2 participants with specific gene mutations, combining two cancer drugs to effectively treat advanced prostate cancer.
Investigators have been awarded a grant to find a better way to protect muscle mass in patients. Muscle mass plays a critical role in quality of life and cancer survival.
研究ers find way to decrease cancer deaths among Black people, begin new lung cancer clinical trial, use app to help people manage cancer, and employ games to reduce chemotherapy after-effects.
Read how scientists reduce infection risk after pancreatic surgery, discover the best cost-effective treatment for prostate cancer, learn which lung cancer patients have the most emergency department visits, 和更多的.
Neeraj Agarwal说医学博士, led a global study analyzing the combination of two cancer drugs to treat metastatic prostate cancer. Results showed this reduces the risk of cancer progression by 55%.
The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo...
Read how researchers discovered genetic markers that hinder pancreatic cancer treatment and mutations that increase sarcoma risk. Then learn how artificial intelligence is helping predict prostate cancer outcomes and see...
Huntsman Cancer Institute celebrates the addition of two endowed chair holders and a fellowship, as well as the renewal of two esteemed endowed chairs. CEO Mary Beckerle, 博士学位, congratulates distinguished...